SecBot SecBot
8-K ·Filed Jun 11, 2026

AIM

AIM ImmunoTech Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed4mo ago SEC0001493152-26-028283
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

Two dilutive offerings in back-to-back days signal acute capital needs ahead of the June 11 NYSE American delisting deadline. Monitor for a shareholder meeting (required by July 21, 2026) to approve the Class J warrants — if approved, dilution accelerates. The combination of immediate share issuance, massive warrant overhang, and potential delisting creates sustained downward pressure. Traders should watch for any compliance extension announcement or reverse split proposal as potential near-term catalysts.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+20d
AIM ▼ -30.28% at T+20d
SHORT call ✓ call won +30.28% · α vs SPY +32.06% · entry $0.4059 → $0.2830
Next anchor: T+60d due 7w ago
Entry anchored
Jun 11, 03:59 PM ET
via exchange tick
T+1d
-4.39%
call +4.39% · α +6.15%
$0.3881
settled 5mo ago
T+5d
-6.41%
call +6.41% · α +7.08%
$0.3799
settled 4mo ago
T+20d
-30.28%
call +30.28% · α +32.06%
$0.2830
settled 4mo ago
T+60d
Pending
due 7w ago

Price Chart

Loading chart...

Executive Summary

AIM ImmunoTech entered a Securities Purchase Agreement for up to ~$2.65M in shares and Class J warrants at $0.5189/share, alongside pre-funded warrants and placement agent warrants. This marks the second dilutive offering in two days (following a ~$1.33M offering on June 10), with the company facing a June 11 NYSE American delisting compliance deadline. The massive warrant coverage (200% of each purchaser's shares) and existing ~40M+ share warrant overhang create severe dilution risk for current holders.

Key Financial Metrics

Offering Size
$2.6M

Key Facts

  • Securities Purchase Agreement for up to $2,648,882 of shares and Class J warrants at $0.5189/share
  • Each purchaser receives Class J warrants for 200% of their purchased shares, exercisable at $0.5189 after stockholder approval
  • Pre-funded warrants issued at $0.001 exercise price to avoid beneficial ownership limits
  • Placement agent (Ladenburg Thalmann) receives 306,494 warrants at $0.6486/share
  • This is the second dilutive offering in 24 hours, following a ~$1.33M offering on June 10 via 424B5
  • NYSE American delisting compliance deadline is June 11, 2026; company may not meet stockholders' equity requirement
  • Existing warrant overhang of ~40M+ shares compounds the dilution from this offering

Financial Impact

Approximately $2.65M raised at $0.5189/share, with Class J warrants for 200% of shares purchased potentially adding 2x additional dilution. Combined with the prior day's ~$1.33M offering and pre-existing ~40M+ warrant overhang, potential fully diluted share count could increase by 50-100%+.

dilutionshare countstockholders' equitydelisting compliance

Risk Factors

  • NYSE American delisting if stockholders' equity compliance not met by June 11 deadline
  • Massive dilution from Class J warrants (200% of offering) and pre-funded warrants exercising at $0.001
  • Potential going concern risk if additional capital cannot be raised
  • Further dilution from outstanding ~40M+ existing warrants and the placement agent's 306,494 warrants
  • Share price pressure from warrant cashless exercises and resale registrations

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028283
Exhibit: ex4-1.htm0001493152-26-028283
Exhibit: ex4-3.htm0001493152-26-028283
Exhibit: ex4-2.htm0001493152-26-028283
31 reports for AIM
Performance horizon
60% Hit rate @ T+20 9 of 15 directional calls Went positive at some point 13 of 18 best @ T+20▲ +57.69%May 14, 2026
Filters
Rows
Reports for AIM — sortable, filterable
TypeNow
Sep 30, 2026
25d ago
DEF 14A
NEUTRAL ★ 3/10
$0.1877awaiting T+20—$0.1600 (−14.76%)
Sep 22, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$0.2156 $0.1662▼ −22.91%▼ −22.35%$0.1600 (−25.79%)
Sep 14, 2026
5w ago
8-K
BEARISH ★ 7/10
$0.2100awaiting T+20—$0.1600 (+23.81%)
Aug 11, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$0.2500 $0.2332▼ −6.72%▼ −5.66%$0.1600 (−36.00%)
Aug 10, 2026
10w ago
8-K
BEARISH ★ 5/10
$0.2630awaiting T+20—$0.1600 (+39.16%)
Aug 10, 2026
10w ago
Press Release
BEARISH ★ 5/10
$0.2630awaiting T+20—$0.1600 (+39.16%)
Aug 5, 2026
11w ago
8-K
MIXED ★ 6/10
$0.2800 $0.2346▼ −16.21%▼ −15.61%$0.1600 (−42.86%)
Aug 3, 2026
11w ago
Press Release
NEUTRAL ★ 4/10
$0.2600 $0.2260▼ −13.08%▼ −14.31%$0.1600 (−38.46%)
Jun 24, 2026
17w ago
EFFECT
BEARISH ★ 7/10
$0.3740 $0.2534▲ +32.25%▲ +34.18%$0.1600 (+57.22%)
Jun 18, 2026
18w ago
S-1
BEARISH ★ 7/10
$0.3799 $0.2730▲ +28.14%▲ +28.67%$0.1600 (+57.88%)
Showing 10 of 31

US Market Status

Market Closed — Opens in 1h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers